| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DRNA | Common Stock | Options Exercise | $90.9K | +10K | +46.47% | $9.09 | 31.5K | Jun 7, 2021 | Direct | |
| transaction | DRNA | Common Stock | Sale | -$330K | -10K | -31.73% | $33.00 | 21.5K | Jun 7, 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DRNA | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -10K | -9.52% | $0.00 | 95K | Jun 7, 2021 | Common Stock | 10K | $9.09 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The Reporting Person sold an aggregate of 10,000 shares of Common Stock on June 7, 2021 (the "Shares Sold") as reported in this Form 4. The Shares Sold represent 1.08% of 923,577 shares of Common Stock, which is the number of shares of Common Stock owned by the Reporting Person prior to the Shares Sold transaction reported in this Form 4, as well as shares issuable upon exercise or settlement of vested and unvested options and restricted stock units held by the Reporting Person as of the date of this report. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2020. |
| F3 | As of the transaction date, the option was fully vested. The option vested in 48 monthly installments over the four-year period with a vesting start date of January 8, 2016, subject in each case to the Reporting Person's continued employment or service with the Issuer through each applicable vesting date. |